Categories
Antivaccine nonsense Politics Popular culture Pseudoscience Skepticism/critical thinking

Monitoring COVID-19 vaccine safety during a pandemic

Last year, the Trump administration essentially disbanded the National Vaccine Program Office, folding it into an office focused on infectious diseases. Then the COVID-19 pandemic hit. What does this mean for monitoring the safety of the soon-to-be-approved COVID-19 vaccines?

Categories
Antivaccine nonsense Bad science Clinical trials Medicine Politics Popular culture

Can we trust the CDC and FDA any more?

Since the COVID-19 pandemic reached the US, increasing concern has been expressed about the politicization of the CDC and FDA due to pressure from the Trump administration to downplay the severity of the pandemic and push out treatments and a vaccine as fast as possible, potentially at the expense of safety. This has led me to a disturbing question: Can I trust the CDC and FDA any more?

Categories
Bad science Clinical trials Medicine Politics Popular culture Skepticism/critical thinking

The FDA’s emergency use authorization of chloroquine and hydroxychloroquine for COVID-19: Dangerous politics, not science

Yesterday, the FDA issued emergency use authorization for hydroxychloroqine and chloroquine to treat COVID-19. Politics, not science, is why.

Categories
Autism Bioethics Cancer Clinical trials Complementary and alternative medicine Integrative medicine Medicine Pseudoscience Quackery

dōTERRA Center for Integrative Oncology: St. Elizabeth Healthcare sells out to an MLM company hawking essential oils

St. Elizabeth Healthcare in Cincinnati recently accepted $5 million from dōTERRA, an MLM company selling essential oils based on dubious claims. This is most definitely not a good look.

Categories
Medicine Politics Popular culture

“Right-to-try” in 2019: Still a failure, still all about the Benjamins (and weakening the FDA)

Federal “right-to-try” legislation was passed and signed into law by President Trump over a year ago. Advocates promised that lots of terminally ill people who were dying then would be saved by having the right to “try” experimental therapies outside of the context of clinical trials. That has not happened. This should come as no surprise, because right-to-try was never about getting experimental drugs to dying patients. It was always about weakening the FDA and making money.